Cite
HARVARD Citation
Monnet, E. et al. (2017). Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS. Clinical pharmacology & therapeutics. 101 (2), pp. 200-208. [Online].